Citrobacter Rodentium Promotes Brain Cognitive Dysfunction of Type 2 Diabetes Mice by Activating FXR Mediated Gut Barrier Damage

Overview

Journal Metab Brain Dis

Publisher Springer

Date 2025 Jan 14

PMID 39808356

Authors

Yuan Li

Song-Tao Chen

Yao-Yuan Zhang

Jin-Feng Qin

Xiao Zhu

Kai Yin

Affiliations

Soon will be listed here.

Abstract

Type 2 diabetes (T2D) is an important risk factor for brain cognitive impairment, but the specific mechanism is still unclear. The imbalance of gut microbiota under pathological conditions (such as an increase in pathogenic bacteria) may be involved in the occurrence of various diseases. The purpose of this study is to investigate the effect of increased abundance of gut Citrobacter rodentium on cognitive function in T2D mice. Our results indicate that an increase in the abundance of Citrobacter rodentium leads to impaired intestinal barrier, elevated expression of inflammatory factors in blood and brain tissue, and promotes cognitive impairment in T2D mice. The specific pathway involves activation of farnesol X receptor (FXR) expression-mediated intestinal barrier dysfunction. The use of intestinal mucosal protectants and FXR inhibitors improved intestinal barrier function and brain cognitive function. Therefore, the research results provide a mechanistic link between the increased abundance of Citrobacter in the gut of T2D mice and brain cognitive function, and provide a reference for the occurrence of brain cognitive dysfunction in T2D.

References

Bancks M, Lovato J, Balasubramanyam A, Coday M, Johnson K, Munshi M . Association of Type 2 Diabetes Subgroups With Cognitive Status Without Modification From Lifestyle Intervention. J Clin Endocrinol Metab. 2022; 108(6):e334-e342. PMC: 10413427. DOI: 10.1210/clinem/dgac706. View

Biessels G, Despa F . Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018; 14(10):591-604. PMC: 6397437. DOI: 10.1038/s41574-018-0048-7. View

Biessels G, Whitmer R . Cognitive dysfunction in diabetes: how to implement emerging guidelines. Diabetologia. 2019; 63(1):3-9. PMC: 6890615. DOI: 10.1007/s00125-019-04977-9. View

Chakrabarti A, Geurts L, Hoyles L, Iozzo P, Kraneveld A, La Fata G . The microbiota-gut-brain axis: pathways to better brain health. Perspectives on what we know, what we need to investigate and how to put knowledge into practice. Cell Mol Life Sci. 2022; 79(2):80. PMC: 8770392. DOI: 10.1007/s00018-021-04060-w. View

Collins J, Keeney K, Crepin V, Rathinam V, Fitzgerald K, Finlay B . Citrobacter rodentium: infection, inflammation and the microbiota. Nat Rev Microbiol. 2014; 12(9):612-23. DOI: 10.1038/nrmicro3315. View

Ghosh S, Whitley C, Haribabu B, Jala V . Regulation of Intestinal Barrier Function by Microbial Metabolites. Cell Mol Gastroenterol Hepatol. 2021; 11(5):1463-1482. PMC: 8025057. DOI: 10.1016/j.jcmgh.2021.02.007. View

Gonzalez F, Jiang C, Patterson A . An Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease. Gastroenterology. 2016; 151(5):845-859. PMC: 5159222. DOI: 10.1053/j.gastro.2016.08.057. View

He K, Hu Y, Shi J, Zhu Y, Mao X . Prevalence, risk factors and microorganisms of urinary tract infections in patients with type 2 diabetes mellitus: a retrospective study in China. Ther Clin Risk Manag. 2018; 14:403-408. PMC: 5834170. DOI: 10.2147/TCRM.S147078. View

Jena P, Sheng L, Nguyen M, Di Lucente J, Hu Y, Li Y . Dysregulated bile acid receptor-mediated signaling and IL-17A induction are implicated in diet-associated hepatic health and cognitive function. Biomark Res. 2020; 8(1):59. PMC: 7648397. DOI: 10.1186/s40364-020-00239-8. View

10.

Joyce S, OMalley D . Regional and conditional variability of FXR: new lessons on ileal inflammation and gut barrier functions. Am J Physiol Gastrointest Liver Physiol. 2024; 327(5):G626-G628. DOI: 10.1152/ajpgi.00226.2024. View

11.

Kayama H, Okumura R, Takeda K . Interaction Between the Microbiota, Epithelia, and Immune Cells in the Intestine. Annu Rev Immunol. 2020; 38:23-48. DOI: 10.1146/annurev-immunol-070119-115104. View

12.

Kesika P, Suganthy N, Sivamaruthi B, Chaiyasut C . Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease. Life Sci. 2020; 264:118627. DOI: 10.1016/j.lfs.2020.118627. View

13.

Little K, Llorian-Salvador M, Scullion S, Hernandez C, Simo-Servat O, Del Marco A . Common pathways in dementia and diabetic retinopathy: understanding the mechanisms of diabetes-related cognitive decline. Trends Endocrinol Metab. 2021; 33(1):50-71. DOI: 10.1016/j.tem.2021.10.008. View

14.

Liu T, Kern J, Jain U, Sonnek N, Xiong S, Simpson K . Western diet induces Paneth cell defects through microbiome alterations and farnesoid X receptor and type I interferon activation. Cell Host Microbe. 2021; 29(6):988-1001.e6. PMC: 8192497. DOI: 10.1016/j.chom.2021.04.004. View

15.

Liu W, Liu Y, Zhang M, Qin M, Yang Y, Liu B . A comparative study of the ameliorative effects of hyaluronic acid oligosaccharides and hyaluronic acid on DSS-induced colitis in mice and research on relevant mechanisms. Food Funct. 2023; 14(14):6482-6495. DOI: 10.1039/d2fo03644d. View

16.

Magliano D, Islam R, Barr E, Gregg E, Pavkov M, Harding J . Trends in incidence of total or type 2 diabetes: systematic review. BMJ. 2019; 366:l5003. PMC: 6737490. DOI: 10.1136/bmj.l5003. View

17.

Galdeano C, Cazorla S, Lemme Dumit J, Velez E, Perdigon G . Beneficial Effects of Probiotic Consumption on the Immune System. Ann Nutr Metab. 2019; 74(2):115-124. DOI: 10.1159/000496426. View

18.

Mauch T, Donohue Jr T, Zetterman R, Sorrell M, Tuma D . Covalent binding of acetaldehyde selectively inhibits the catalytic activity of lysine-dependent enzymes. Hepatology. 1986; 6(2):263-9. DOI: 10.1002/hep.1840060218. View

19.

Meynier M, Baudu E, Rolhion N, Defaye M, Straube M, Daugey V . AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms. Gut Microbes. 2022; 14(1):2022997. PMC: 8803069. DOI: 10.1080/19490976.2021.2022997. View

20.

Mou Y, Du Y, Zhou L, Yue J, Hu X, Liu Y . Gut Microbiota Interact With the Brain Through Systemic Chronic Inflammation: Implications on Neuroinflammation, Neurodegeneration, and Aging. Front Immunol. 2022; 13:796288. PMC: 9021448. DOI: 10.3389/fimmu.2022.796288. View